Drug intelligence / Profile preview

PostbiotiX Motility

Development stage: Unknown
Lead developer: Postbiotica
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

PostbiotiX Motility is a postbiotic food supplement developed by Postbiotica to regulate and balance intestinal transit, specifically targeting sluggish or "lazy" intestine and constipation. The product is formulated using Postbiotica's proprietary PBTech® technology, which involves a patented natural fermentation process. Its primary active ingredient is fermented fructooligosaccharides (FOS) derived from *Lactobacillus paracasei* CNCM I-5220. Additionally, it contains botanical extracts such as mallow, plum, and tamarind, along with vitamin B3 (niacin). It works by modulating gut function and motility to maintain normal stool volume and consistency while supporting the intestinal mucosa.

Brand names: PostbiotiX Motility
Other names: Motility

Beyond the preview

Go deeper on PostbiotiX Motility.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PostbiotiX Motility.

Explore the full profile